Shinobu Hirayama | Healthcare Data Analysis | Research Excellence Award

Published on 04/12/202504/12/2025 by Research Data Analysis

Ms. Shinobu Hirayama | Healthcare Data Analysis | Research Excellence Award

Meiji Pharmaceutical University | Japan

Shinobu Hirayama is a Japanese clinical microbiology researcher and pharmacist whose work focuses on antimicrobial stewardship, antimicrobial resistance, and clinical infectious diseases. She holds a Bachelor of Pharmacy from Meiji Pharmaceutical University (1997) and is currently pursuing a PhD in Microbiology. With long-standing experience at Toho University Omori Medical Centre—most recently as Assistant Director of the Department of Pharmacy—she has contributed extensively to infection control and antimicrobial management. Her research portfolio includes peer-reviewed publications on carbapenem-resistant Enterobacterales, antimicrobial dosing metrics, vancomycin-associated kidney injury, and therapeutic strategies for COVID-19 and Clostridioides difficile. She has presented her work at major national and international conferences, including APSMM. Hirayama’s scholarly output includes 5 peer-reviewed documents, cited by 122 documents, with an h-index of 2, reflecting her growing impact in clinical microbiology and antimicrobial stewardship research. She received the Encouragement Award from the Japanese Society of Chemotherapy (2016) for developing a novel evaluation method for carbapenem stewardship. Her current work aims to refine antimicrobial and antifungal stewardship practices to improve patient outcomes and limit resistance development.

Profile : Scopus

Featured Publications

Ohtani, M., Yokoo, T., Miyazaki, T., Yasuda, H., Nishikawa, E., Tomida, M., Tsukada, M., Sato, E., Hirayama, S., Murakami, H., Yoshizawa, S., Matsumoto, T., & Tateda, K.
“Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study” in Journal of Pharmaceutical Health Care and Sciences, 11(1): 94.

Hirayama, S., Otani, M., Murakami, H., Sakamoto, M., Tateda, K., Matsumoto, T., & Sugita, T. “Association between antimicrobial use and the detection rates of carbapenem-resistant Enterobacterales: long-term surveillance results from a single centre” in Infection Prevention in Practice, In Press.

Ohtani, M., Yoshizawa, S., Miyazaki, T., Kumade, E., Hirayama, S., Sakamoto, M., Murakami, H., Maeda, T., Ishii, Y., Matsumoto, T., & Tateda, K. “Clinical efficacy of therapeutic agents for Clostridioides difficile infection based on four severity classifications” in Japanese Journal of Infectious Diseases, 77(5): 281–284.

Uekusa, S., Hanai, Y., Hirayama, S., Yokoo, T., Hasegawa, T., Shimoyama, K., Kusano, A., Nishizawa, K., Matsumoto, T., & Matsuo, K. “Vancomycin hydrochloride as a risk factor for acute kidney injury: a retrospective study” in Pharmacology, 108(5): 444–450.

M D Zidan | Engineering | Best Researcher Award

Published on 03/10/202503/10/2025 by Research Data Analysis

Prof. M D Zidan | Engineering | Best Researcher Award

AECS | Syria

Prof. Mohammed D. Zidan is a Professor of Laser Physics at the Syrian Atomic Energy Commission (AEC), where he currently heads the Department of Physics and previously led the Laser Division for over three decades. He earned his B.Sc. in Physics and Chemistry from the University of Aleppo (1984), an M.Sc. in Laser Spectroscopy (1988), and a Ph.D. in Laser Spectroscopy (1993) from the University of Sussex, UK. His research covers laser physics, nonlinear optics, optical limiting, carbon nanomaterials, quantum dots, and medical laser applications, with more than 70 publications in international journals. Prof. Zidan has represented Syria at major international conferences, including Laser Physics and CLEO/Europe, and has organized national scientific meetings on laser science. He has been a Lecturer in Medical Physics at Al-Sham Private University since 2017, and his teaching spans general physics, medical physics, laser spectroscopy, and optics for engineering. Promoted to Full Professor in 2003, Prof. Zidan continues to advance laser spectroscopy and nonlinear optical research, contributing significantly to photonics development in Syria and beyond.

Profile : Scopus

Featured Publication

M. D. Zidan, A. Allahham, A. Ghanem, N. Mousa (2025). Thermal lens study and all optical switching of DB dye solution. Journal of Optoelectronics and Advanced Materials, 27(3–4).

M. D. Zidan, A. Allahham, A. Ghanem, N. Mousa (2025). Wavelength dependence of thermal lens and all-optical switching of DB dye solution. Spectroscopy Letters.

M. D. Zidan, A. Allahham, A. Ghanem, N. Mousa, B. Abdallah, A. Al Salman (2025). All-optical switching behavior of CdSe quantum dots solution. Journal of Nonlinear Optical Physics & Materials.

M. D. Zidan, M. M. Al-Ktaifani, A. Allahham (2024). Thermal lens effect induced by CW laser beam in tetracarbonyl(2,2ʹ-bipyridyl)chromium(0) complex. Journal of Optoelectronics and Advanced Materials, 26(9–10), 362–367.

M. D. Zidan, A. Allahham, A. Ghanem, N. Mousa, B. Abdallah, A. Al Salman (2024). Effect of laser powers and sample positions on the self-diffraction ring patterns in CdSe quantum dots solution. Optik, 311, 171948.

Elshaimaa Arafa – New medication Award – Women Researcher

Published on 16/03/202416/03/2024 by Research Data Analysis

Prof. Elshaimaa Arafa - New medication Award - Women Researcher

Ajman University of Science and Technology - United Arab Emirates

Author Profile

Early Academic Pursuits

Prof. El-Shaimaa A. Arafa, Ph.D., embarked on her academic journey with a Bachelor's degree in Pharmaceutical Sciences from Cairo University, where she graduated with honors and an exceptional GPA of 3.96 out of 4.0. This solid foundation in pharmaceutical sciences laid the groundwork for her subsequent achievements in academia.

Driven by a passion for advancing her knowledge and skills, Prof. Arafa pursued a Master's degree in Pharmacology and Toxicology from Cairo University, where she conducted research on the effectiveness of gastropathy-preventing drugs. Her dedication to research excellence led her to achieve a Master's degree with distinction.

Building upon her Master's studies, Prof. Arafa ventured into the realm of international education and research collaboration. She pursued a Ph.D. in Pharmacology, a joint program between Cairo University in Egypt and The Ohio State University in the USA. Her doctoral research focused on elucidating the molecular mechanisms underlying the modulatory effects of naturally occurring compounds on cancer therapy efficacy. This interdisciplinary approach underscored her commitment to addressing complex biomedical challenges.

During her academic journey, Prof. Arafa also completed pre-master courses at Cairo University, ensuring a comprehensive understanding of foundational subjects such as Statistics, Computer Sciences, and English Language, alongside specialized coursework in Pharmacology and Toxicology.

Professional Endeavors

Prof. Arafa's professional journey spans various academic positions and research roles, reflecting her versatility and expertise in pharmacology and toxicology. She has held teaching and research positions at esteemed institutions such as Beni-Suef University in Egypt, Taif University in Saudi Arabia, and Ajman University in the United Arab Emirates (UAE).

Her academic appointments include Assistant, Associate, and Professor positions, demonstrating her progressive leadership in academia. Prof. Arafa's contributions extend beyond traditional teaching roles; she has actively participated in curriculum development and course instruction for both graduate and undergraduate pharmacy students. Her diverse teaching portfolio encompasses courses ranging from basic pharmacology to specialized topics such as drug interactions and clinical pharmacology.

In addition to her teaching responsibilities, Prof. Arafa has made significant contributions to scientific research in pharmacology and toxicology. Her research expertise spans cancer biology, cell signaling, oxidative stress, and molecular mechanisms of drug action. Dr. Arafa has published extensively in reputable peer-reviewed journals, with her research findings contributing to advancements in cancer therapy, drug safety, and pharmacological interventions.

Contributions and Research Focus On New medication Award

Prof. Arafa's research endeavors have primarily focused on elucidating the molecular mechanisms of natural compounds in cancer therapy and oxidative stress-related disorders. Her pioneering work has shed light on the potential therapeutic applications of natural products in mitigating chemotherapy-induced toxicities, oxidative stress, and inflammation.

One of her notable research contributions includes investigating the protective effects of various natural compounds against chemotherapy-induced testicular injury, cardiac effects, and pulmonary fibrosis in preclinical models. Through a multidisciplinary approach encompassing in vitro and in vivo studies, Prof. Arafa has delineated the intricate signaling pathways involved in the pharmacological actions of these compounds.

Furthermore, Prof. Arafa's research has implications for drug development and translational medicine, emphasizing the importance of harnessing the therapeutic potential of natural compounds for combating clinical disorders. Her investigations into the pharmacological properties of medicinal plants and herbs have provided valuable insights into novel therapeutic targets and drug discovery strategies.

Accolades and Recognition

Prof. Arafa's exemplary contributions to academia and research have been recognized through various accolades and awards. She has received prestigious honors such as the Faculty Excellence in Research award from Ajman University and the Best Research Award from Beni-Suef University. Her research findings have been acknowledged internationally, with awards for best professional posters and presentations at renowned conferences such as the Dubai International Pharmaceuticals and Technologies Conference (DUPHAT).

Additionally, Prof. Arafa has been the recipient of fellowships and grants, including the BioVision Nxt Fellowship Award, which enabled her participation in the international Life Sciences Forum in Lyon, France. These accolades underscore her outstanding achievements and the significance of her research contributions in the field of pharmacology and toxicology.

Impact and Influence

Prof. Arafa's scholarly endeavors have made a profound impact on both academic scholarship and clinical practice. Her research publications have been widely cited within the scientific community, indicating the significance of her findings in advancing pharmacological knowledge and clinical therapeutics.

Moreover, Prof. Arafa's commitment to mentorship and academic leadership has fostered the development of future generations of pharmacologists and researchers. Through her mentorship programs and educational initiatives, she has inspired and guided aspiring scholars to pursue excellence in pharmaceutical sciences and biomedical research.

Legacy and Future Contributions

As a respected educator, researcher, and mentor, Prof. Arafa's legacy extends far beyond her individual achievements. Her dedication to advancing pharmacological research and promoting scientific innovation has left an indelible mark on the academic community.

Looking ahead, Prof. Arafa continues to explore new frontiers in pharmacology and toxicology, with a focus on translational research and personalized medicine. Her ongoing efforts to bridge the gap between basic science discoveries and clinical applications hold promise for addressing unmet medical needs and improving patient outcomes.

In summary, Prof. El-Shaimaa A. Arafa's remarkable academic pursuits, groundbreaking research endeavors, and enduring commitment to excellence exemplify her as a trailblazer in the field of pharmacology and toxicology. Through her visionary leadership and impactful contributions, she continues to shape the future of pharmacological research and inspire the next generation of scientists.